Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure
Alimentary Pharmacology & Therapeutics · 2026-10-16
DOI: 10.1111/apt.71059 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-10-16. Written by Yakup Demir. Institution: Department of Infectious Diseases and Clinical Microbiology, Memorial Diyarbakir Hospital, Diyarbakir, Turkiye. Cited 1 times so far (Crossref); 6 references.
Abstract (original language)
Abstract non disponibile.
Authors and institutions
- Department of Infectious Diseases and Clinical Microbiology, Memorial Diyarbakir Hospital, Diyarbakir, Turkiye.
ORCID profiles: Yakup Demir
Cite
APA
Demir, Y. (2026). Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71059
Vancouver
Demir Y. Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71059
BibTeX
@article{Demir2026,
author = {Demir, Yakup},
title = {Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.71059}
}
EUVIMED